PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1054
https://www.valueinhealthjournal.com/article/S1098-3015(11)02616-7/fulltext
Title : PRM23 General Methodological Issues in Cost-Effectiveness Analysis Inspired by the Assessment of Dasatinib, Nilotinib and Imatinib for Chronic Myeloid Leukaemia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02616-7&doi=10.1016/j.jval.2011.08.1054
First page : A425
Section Title : Research On Methods
Open access? : No
Section Order : 1016
Categories :
Tags :
Regions :
ViH Article Tags :